| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |